David Sarid
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Prostate Cancer Treatment and Research 12
- Renal cell carcinoma treatment 8
- Prostate Cancer Diagnosis and Treatment 3
- Oncology 14
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Ido Wolf (3 shared papers)Adva Yeheskel (1 shared paper)Addie Dvir (2 shared papers)Rinath Jeselsohn (1 shared paper)Keren Merenbakh-Lamin (1 shared paper)Tamar Rubinek (1 shared paper)Baruch Klein (1 shared paper)Roman Yelensky (1 shared paper)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (3 papers)Prostate Cancer and Prostatic Diseases (2 papers)Clinical Genitourinary Cancer (2 papers)The International Journal of Biological Markers (2 papers)
- Partner nations
- IsraelUnited StatesSouth Korea
In The Last Decade
David Sarid
43 papers receiving 603 citations
Peers
Comparison fields: 5 of 63
- Oncology 235
- Cancer Research 128
- Pulmonary and Respiratory Medicine 201
- Genetics 153
- Radiology, Nuclear Medicine and Imaging 72
Countries citing papers authored by David Sarid
This map shows the geographic impact of David Sarid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sarid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sarid more than expected).
Fields of papers citing papers by David Sarid
This network shows the impact of papers produced by David Sarid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sarid. The network helps show where David Sarid may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sarid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 294 | |
| 2 | 2004 | 40 | |
| 3 | 2017 | 37 | |
| 4 | 2019 | 22 | |
| 5 | 2011 | 18 | |
| 6 | 2016 | 18 | |
| 7 | 2021 | 18 | |
| 8 | 2016 | 15 | |
| 9 | 2006 | 15 | |
| 10 | 2021 | 13 | |
| 11 | 2006 | 13 | |
| 12 | 2021 | 12 | |
| 13 | Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer. | 2006 | 11 |
| 14 | 2022 | 11 | |
| 15 | 2019 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2002 | 6 | |
| 18 | 2016 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2022 | 4 |
About David Sarid
David Sarid is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 46 papers that have together received 612 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Renal cell carcinoma treatment (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (235 citations), Cancer Research (128 citations), Pulmonary and Respiratory Medicine (201 citations), Genetics (153 citations) and Radiology, Nuclear Medicine and Imaging (72 citations). David Sarid has collaborated with scholars based in Israel, United States and South Korea. Frequent co-authors include Ido Wolf, Adva Yeheskel, Addie Dvir, Rinath Jeselsohn, Keren Merenbakh-Lamin, Tamar Rubinek, Baruch Klein, Roman Yelensky, Vincent A. Miller and Myles Brown. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Prostate Cancer and Prostatic Diseases, Clinical Genitourinary Cancer and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.